Trial intelligence / Profile preview

Randomised trial of detrusor botulinum toxin injection (BOTOX) compared to placebo in women with idiopathic detrusor overactivity

2004-002981-39Phase 4Completed

Sponsor
University Hospitals of Leicester NHS Trust
Start
Feb 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial in idiopathic detrusor overactivity (IDO) comparing BOTOX intradetrusor injection with Placebo intradetrusor injection (2 arms). Primary endpoint: Diary recorded urinary voiding frequency per 24 hours at 6 months. Started Feb 2005; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

idiopathic detrusor overactivity (IDO)

Beyond the preview

Go deeper on 2004-002981-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002981-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call